Mid-life women being let down by PHARMAC, say menopause experts

6 June 2023 - New Zealand women in mid-life are being let down by Pharmac, say two doctors specialising in ...

Read more →

New Zealand Pharmaceutical Schedule - 1 June 2023

1 June 2023 - The June 2023 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...

Read more →

Consultation for various vaccine supply agreements

29 May 2023 - PHARMAC is consulting on potential new supply agreements for multiple vaccines listed in the National Immunisation Schedule. ...

Read more →

Helping with health costs: prescription charge scrapped, providing cheaper medicine

18 May 2023 - The Chris Hipkins Government is reducing the cost of health care for New Zealand households by ...

Read more →

'Would they run out of Viagra?' PHARMAC slammed for huge shortage of HRT

15 May 2023 - Northland women going through menopause are starting to suffer from a raft of “horrible” symptoms caused ...

Read more →

Ovarian cancer: Bay of Plenty mother spends more than $130,000 on treatments

12 May 2023 - Four cancer treatments in three years: $132,775. ...

Read more →

Cases of invasive pneumococcal disease 'sharply' rose after PHARMAC downgraded vaccine programme - study

10 May 2023 - A few years after New Zealand downgraded its vaccine programme against pneumococcal disease, cases of the ...

Read more →

PHARMAC amends funding rules on dispensing of ADHD medicines

1 May 2023 - PHARMAC has announced an amendment to the Pharmaceutical Schedule from 1 June 2023, to align funding rules ...

Read more →

New Zealand Pharmaceutical Schedule - 1 May 2023

The May 2023 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...

Read more →

Time taken for PHARMAC funding decisions ‘too long’, says Medicines NZ

26 April 2023 - It takes the nation's drug-buying agency, PHARMAC, an average of 7.7 years to make funding decisions ...

Read more →

PHARMAC announces new Deputy Medical Director Māori

19 April 2023 - PHARMAC has welcomed Dr Kiri Prentice (Ngāi Tūhoe and Ngāti Awa) to the newly established role ...

Read more →

PHARMAC funds second treatment for spinal muscular atrophy

11 April 2023 - PHARMAC has announced the funding of risdiplam (Evrysdi) for people with the rare genetic disorder spinal muscular ...

Read more →

PHARMAC shares next steps in reviewing rule 8.1b

5 April 2023 - PHARMAC’s consultation on rule 8.1b of the Pharmaceutical Schedule has now closed. ...

Read more →

PHARMAC seeking feedback on the COVID-19 anti-viral molnupiravir

4 April 2023 - PHARMAC are consulting on the role of molnupiravir in New Zealand’s portfolio of COVID-19 treatments.  ...

Read more →

New Zealand Pharmaceutical Schedule - 1 April 2023

1 April 2023  The April 2023 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...

Read more →